Literature DB >> 18843251

Serum level of cardiac troponin I in pediatric patients with sepsis or septic shock.

Norma Suely Oliveira1, Valmin Ramos Silva, Jane Sant' Ana Castelo, Jorge Elias-Neto, Fausto Edmundo Lima Pereira, Werther Brunow Carvalho.   

Abstract

OBJECTIVES: To evaluate serum level of contractile protein troponin I (cTnI) within the 24 hrs of sepsis and septic shock diagnosis in children and to correlate with the outcome (discharge from hospital or death).
DESIGN: Prospective, observational study.
SETTING: Pediatric Intensive Care Unit, at Hospital Infantil Nossa Senhora da Glória, Vitória, ES, Brazil. PATIENTS: Two hundred eighteen consecutive admissions of septic patients.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Measurement of serum cTnI (IMMULITE cTnI assay, Diagnostic Product Corporation, Los Angeles, CA) and creatine kinase MB isoenzyme and electrocardiographic tracings were performed within 24 hrs of sepsis or septic shock diagnosis. The pediatric index of mortality, pediatric index of mortality-2 was calculated for each patient. Primary diseases most frequently associated were pneumonia (42%) and meningitis (18%). The overall mortality was 12% (27 cases), 2.7% in the sepsis group, and 33% in the septic shock group. Both Pediatric Index of Mortality and Pediatric Index of Mortality-2 reached good discrimination. Electrocardiographic abnormalities were infrequent (9.2%). Abnormal serum levels of cTnI occurred in ten (4.5%) patients, significantly more frequent in the septic shock group than in sepsis group (13% vs. 0.7%, respectively; p = 0.000). Although frequency of elevated serum cTnI was significantly higher in nonsurvivors than in survivors (5 of 27 vs. 5 of 191, respectively; p = 0.003), this frequency not showed significant relationship with electrocardiogram alteration, creatine kinase MB isoenzyme levels, etiology of sepsis, or length of hospital days. In addition, a logistic regression analysis, taking in account age, gender, length of hospital days, sepsis definition, presence of meningitis, creatine kinase MB isoenzyme, and cTnI serum levels, demonstrated that severity of septic disease was the only variable significantly associated with the death.
CONCLUSIONS: Evaluation of serum levels of cTnI within the first 24 hrs of diagnosis of sepsis or septic shock in children was not better than creatine kinase MB isoenzyme or clinical evaluation, to predict the outcome (death or discharge from hospital) of septic process.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18843251     DOI: 10.1097/PCC.0b013e31817e2b33

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  10 in total

1.  Global Case-Fatality Rates in Pediatric Severe Sepsis and Septic Shock: A Systematic Review and Meta-analysis.

Authors:  Bobby Tan; Judith Ju-Ming Wong; Rehena Sultana; Janine Cynthia Jia Wen Koh; Mark Jit; Yee Hui Mok; Jan Hau Lee
Journal:  JAMA Pediatr       Date:  2019-04-01       Impact factor: 16.193

2.  Neonatal Myocardial Perfusion in Right Ventricle Dependent Coronary Circulation: Clinical Surrogates and Role of Troponin-I in Postoperative Management Following Systemic-to-Pulmonary Shunt Physiology.

Authors:  Dennis H VanLoozen; Kenneth A Murdison; Anastasios C Polimenakos
Journal:  Pediatr Cardiol       Date:  2018-07-28       Impact factor: 1.655

Review 3.  Raised cardiac troponin in intensive care patients with sepsis, in the absence of angiographically documented coronary artery disease: A systematic review.

Authors:  Vasileios Zochios; Kamen Valchanov
Journal:  J Intensive Care Soc       Date:  2014-12-09

Review 4.  Role of complement C5a and histones in septic cardiomyopathy.

Authors:  Fatemeh Fattahi; Lynn M Frydrych; Guowu Bian; Miriam Kalbitz; Todd J Herron; Elizabeth A Malan; Matthew J Delano; Peter A Ward
Journal:  Mol Immunol       Date:  2018-06-18       Impact factor: 4.407

5.  High-Sensitivity Troponin T Testing for Pediatric Patients in the Emergency Department.

Authors:  Alan P Wang; James L Homme; M Yasir Qureshi; Yader Sandoval; Allan S Jaffe
Journal:  Pediatr Cardiol       Date:  2021-11-17       Impact factor: 1.655

Review 6.  Complement and sepsis-induced heart dysfunction.

Authors:  Fatemeh Fattahi; Peter A Ward
Journal:  Mol Immunol       Date:  2016-12-05       Impact factor: 4.407

7.  Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome.

Authors:  Helge Røsjø; Marjut Varpula; Tor-Arne Hagve; Sari Karlsson; Esko Ruokonen; Ville Pettilä; Torbjørn Omland
Journal:  Intensive Care Med       Date:  2010-10-12       Impact factor: 17.440

8.  Criteria for Pediatric Sepsis-A Systematic Review and Meta-Analysis by the Pediatric Sepsis Definition Taskforce.

Authors:  Kusum Menon; Luregn J Schlapbach; Samuel Akech; Andrew Argent; Paolo Biban; Enitan D Carrol; Kathleen Chiotos; Mohammod Jobayer Chisti; Idris V R Evans; David P Inwald; Paul Ishimine; Niranjan Kissoon; Rakesh Lodha; Simon Nadel; Cláudio Flauzino Oliveira; Mark Peters; Benham Sadeghirad; Halden F Scott; Daniela C de Souza; Pierre Tissieres; R Scott Watson; Matthew O Wiens; James L Wynn; Jerry J Zimmerman; Lauren R Sorce
Journal:  Crit Care Med       Date:  2022-01-01       Impact factor: 9.296

9.  Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine.

Authors:  Sangeeta Mehta; John Granton; Anthony C Gordon; Deborah J Cook; Stephen Lapinsky; Gary Newton; Kris Bandayrel; Anjuli Little; Chuin Siau; Dieter Ayers; Joel Singer; Terry C K Lee; Keith R Walley; Michelle Storms; D James Cooper; Cheryl L Holmes; Paul Hebert; Jeffrey Presneill; James A Russell
Journal:  Crit Care       Date:  2013-06-20       Impact factor: 9.097

10.  Longitudinal Study of CPK-MB and Echocardiographic Measures of Myocardial Dysfunction in Pediatric Sepsis: Are Patients with Shock Different from Those without?

Authors:  Arun K Baranwal; Geddam Deepthi; Manoj K Rohit; Muralidharan Jayashree; Suresh K Angurana; Praveen Kumar-M
Journal:  Indian J Crit Care Med       Date:  2020-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.